The United People of Canada

CDC Data Shows More US Children are Overexposed to Fluoride Than Ever Before

Retrieved on: 
Monday, May 8, 2023

NORTH SUTTON, N.H., May 8, 2023 /PRNewswire/ -- Government data shows that tens-of-millions of U.S. residents have visible signs of overexposure to fluoride.

Key Points: 
  • NORTH SUTTON, N.H., May 8, 2023 /PRNewswire/ -- Government data shows that tens-of-millions of U.S. residents have visible signs of overexposure to fluoride.
  • The US Centers For Disease Control's (CDC) National Health and Nutrition Examination Survey (NHANES) has consistently found skyrocketing rates of dental fluorosis, reports the Fluoride Action Network .
  • The CDC reported that 41% of adolescents (12 to 15) had dental fluorosis in 2004.
  • At the time, this was an increase of over 400% from the rates found 60 years prior.

New Cochrane Review Recognizes the Powerful Impact of Cranberry for UTI Prevention

Retrieved on: 
Thursday, April 27, 2023

CARVER, Mass., April 27, 2023 /PRNewswire/ -- In the most comprehensive review to date, new findings published in The Cochrane Database of Systematic Reviews have positive news for those who suffer from urinary tract infections (UTIs). Cranberry juice, and cranberry supplements, have been shown to prevent and reduce the risk of repeat UTIs in women, children, and other at-risk individuals.

Key Points: 
  • Cranberry juice, and cranberry supplements, have been shown to prevent and reduce the risk of repeat UTIs in women, children, and other at-risk individuals.
  • The science has long shown that cranberry products can prevent UTIs, and now this review further bolsters evidence to prove their efficacy.
  • Study authors conducted a large-scale meta-analysis of 50 clinical trials, in which the objective was to assess the effectiveness of cranberry products in preventing UTIs in susceptible populations.
  • We have determined that PACs in juice-based products are most effective for UTI prevention and should be consumed daily2," says Howell.

Helius Medical Technologies to Spotlight Expanded Authorizations for its PoNS Device at 2023 American Academy of Neurology Annual Meeting, Booth 1685

Retrieved on: 
Monday, April 17, 2023

Helius’s presence at the conference comes at a time when PoNS is seeking additional indications for neurological conditions that lead to gait and/or balance impairment.

Key Points: 
  • Helius’s presence at the conference comes at a time when PoNS is seeking additional indications for neurological conditions that lead to gait and/or balance impairment.
  • Health Canada authorized PoNS for short-term treatment of balance and gait deficit due to MS, mild-to-moderate traumatic brain injury (mmTBI) and, in the past month, stroke .
  • “This is the right time to exhibit at the AAN conference,” said Helius President and Chief Executive Officer Dane Andreeff.
  • Tyler M, Skinner K, Prabhakaran V, Kaczmarek K, Danilov Y. Translingual neurostimulation for the treatment of chronic symptoms due to mild-to-moderate traumatic brain injury.